LifeMD, Inc. (LFMD) Tops Q3 EPS by 21c ; Offers Guidance

LifeMD, Inc. (NASDAQ: LFMD) reported Q3 EPS of $0.09, $0.21 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $53.4 million versus the consensus estimate of $53.8 million.

GUIDANCE:

LifeMD, Inc. sees Q4 2024 revenue of $57-58 million, versus the consensus of $57.66 million.

LifeMD, Inc. sees FY2024 revenue of ~$205 million, versus the consensus of $206 million.

For earnings history and earnings-related data on LifeMD, Inc. (LFMD) click here.

You May Also Be Interested In

• Goldman Sachs (GS) Reiterated at Market Perform by Citizens on Constructive Backdrop
• NRC Health (NRC) Reiterated at Market Outperform by Citizens Ahead of Annual Forum
• H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook